Back to results
RecruitingPhase 2

Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease

NCT04838301

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Perseverance Research Center

Scottsdale, Arizona, United States

+9 additional locations

Contact

Claudia M Lopez, BS

520-626-6276claudiml@arizona.edu
View on ClinicalTrials.gov
Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease — TrialFind